Lindis Biotech GmbH | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
Lindis Biotech GmbH

BRIEF

published on 11/19/2024 at 10:12, 2 days ago

LINDIS Biotech Partners with Pharmanovia for Catumaxomab Launch

Cancer Therapy Malignant Ascites Catumaxomab LINDIS Biotech Pharmanovia
PRESS RELEASE

published on 11/19/2024 at 10:07, 2 days ago

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
LINDIS Biotech signs licensing agreement with Pharmanovia for the commercialization of Catumaxomab, a trifunctional bi-specific monoclonal antibody for malignant ascites treatment

Licensing Agreement Malignant Ascites Catumaxomab LINDIS Biotech Pharmanovia
BRIEF

published on 10/21/2024 at 09:05, 1 month ago

LINDIS Biotech Achieves Key Milestone for Cancer Treatment in Europe

European Commission CHMP Approval KORJUNY® Malignant Ascites Catumaxomab
PRESS RELEASE

published on 10/21/2024 at 09:00, 1 month ago

LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union
LINDIS Biotech receives Positive CHMP Opinion for KORJUNY® (catumaxomab) in the European Union, becoming the only drug approved for intraperitoneal treatment of malignant ascites in adults with EpCAM-positive carcinomas

CHMP Opinion Malignant Ascites Catumaxomab LINDIS Biotech KORJUNY

Accesswire

Published on 11/21/2024 at 10:03, 37 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 40 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 40 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 5 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 15 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 10 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 35 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 38 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 40 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 40 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 20 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 55 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 55 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE